Favipiravir

India gets 12L Favipiravir, 6.9L Remdesivir in foreign aid

In Covid-19 year, Cipla reports Rs 2,389 crore profit

Brinton Pharmaceuticals ramps up production of anti-Covid drug

Covid-19: Vivimed Labs gets govt nod to manufacture, sell Favipiravir tablets in India

COVID-19 news from across the nation

SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19

Top 10 News @ 7 PM

DCGI allows phase 4 clinical trial of Covid-19 drug Favipiravir

DCGI asks for more details over Favipiravir 600 mg and 800 mg tablets

Jenburkt Pharma launches COVID-19 drug at Rs 39 per tablet

Four held for illegally procuring, selling COVID-19 antiviral drugs in Telangana

Glenmark initiates FabiFlu post marketing surveillance, cuts prices

Glenmark Pharma cuts price of COVID-19 drug by 27% to Rs 75/tablet

Activists question fast-track approval to remdesivir, favipiravir

DCGI approves use of favipiravir for restricted emergency use in moderate Covid-19 cases